To reveal the potential prognostic value of Ars2 mRNA expression for AML patients, we used genomic analysis and visualization platform databases (http://r2.amc.nl, http://watson.compbio.iupui.edu, and https://cancergenome.nih.gov). This evidence concerns the gene SRRT and acute myeloid leukemia.